Biotech Values

[dewophile]

The usual course of business as you know is to release topline data and withhold details for a medical conference and or publication so the rationale of withholding top line data to get into a journal doesn’t pass the smell test
The fact they’re waiting for more analysis before they release data suggests an effort to data mine so they have some positive spin because the top line is not so good